Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1999;85:1113-1114

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sato, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sato, T.
(Circulation Research. 1999;85:1113.)
© 1999 American Heart Association, Inc.


Editorials

Signaling in Late Preconditioning

Involvement of Mitochondrial KATP Channels

Toshiaki Sato

From the Department of Physiology, Oita Medical University, Oita, Japan.

Correspondence to Toshiaki Sato, MD, PhD, Department of Physiology, Oita Medical University, 1-1 Idaigaoka, Hasama, Oita 879-5593, Japan. E-mail tsato@oita-med.ac.jp


Key Words: preconditioning • mitochondria • protein kinase C • protein tyrosine kinase


*    Introduction
 
Lethal injury to the heart can be dramatically blunted by brief periods of prior ischemia.1 Such an endogenous cardioprotective mechanism, known as ischemic preconditioning (IPC), exists in all species examined to date, including humans.2 IPC occurs in a biphasic pattern of myocardial protection: an early phase (classic IPC), which develops immediately and lasts approximately 2 hours after the IPC stimulus, and a delayed phase (late IPC or second window of protection), which reappears after 24 hours and lasts at least 72 hours.3 4 Despite intensive investigation, the cellular mechanism of IPC still remains obscure, although important clues are beginning to emerge.

A number of substances and signaling pathways have been proposed to be involved in mediating the cardioprotective effect of IPC (reviewed in Downey and Cohen5 ). Nevertheless, considerable evidence has suggested that ATP-sensitive K+ (KATP) channels may serve as the end effectors in this process.6 Although the cardioprotective effects were initially attributed to plasma membrane KATP channels, the degree of action potential shortening can be divorced from the extent of protection.7 8 Instead, it now seems much more likely that KATP channels in mitochondrial inner membrane (mitoKATP channels) are the dominant players. The studies of the mitoKATP channel were facilitated by the identification of a selective opener and a selective blocker of mitoKATP channels (selective relative to cardiac sarcolemmal KATP channels, by at least three orders of magnitude), namely diazoxide and 5-hydroxydecanoate.9 10 The mitoKATP channel opener diazoxide mimics the infarct size–limiting effects of classic IPC, whereas the mitoKATP channel blocker . . . [Full Text of this Article]